Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  AIDS (London)

• Publication date

  2008-09-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/QAD.0b013e32830a5043PMID 18753934
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: Defining a consensus terminology

  2011cited by this paper
• Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: Data from the Italian Registry Investigative Neuro AIDS (IRINA)

  2011cited by this paper
• Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis

  2011cited by this paper
• Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: A monocenter observational study with clinical and JC virus load monitoring

  2011cited by this paper
• Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy

  2008cited by this paper
• Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

  2008cited by this paper
• Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.

  2005cited by this paper
• treatment of

  2005cited by this paper
• Detection of JC Virus-Specific Cytotoxic T Lymphocytes in Healthy Individuals

  2004cited by this paper
• Progressive Multifocal Leukencephalopathy in Patients on Highly Active Antiretroviral Therapy: Survival and Risk Factors of Death

  2004cited by this paper
• Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America.

  2004cited by this paper
• Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy

  2003cited by this paper
• Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.

  2003influential reference
• A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS

  2002cited by this paper
• JC virus load in progressive multifocal leukoencephalopathy: analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival, and the volume of neurological lesions.

  2002cited by this paper
• GENDER DIFFERENCE IN HIV RNA LEVELS: A META-ANALYSIS OF PUBLISHED STUDIES

  2002influential reference
• Use of Cidofovir in Progressive Multifocal Leukoencephalopathy

  2001cited by this paper
• Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study

  2001cited by this paper
• Failure of cidofovir therapy in progressive multifocal leukoencephalopathy unrelated to human immunodeficiency virus.

  2001cited by this paper
• The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.

  2000cited by this paper
• Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy

  2000cited by this paper
• Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.

  1999cited by this paper
• Acute Fulminant Multiple Sclerosis and Plasma Exchange

  1999cited by this paper
• Brief Communications Expedited Publication HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy

  1999cited by this paper
• Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy

  1999cited by this paper
• Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV.

  1999cited by this paper
• Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era.

  1999cited by this paper
• Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy

  1999cited by this paper
• Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.

  1999cited by this paper
• Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.

  1998cited by this paper
• Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside.

  1998cited by this paper
• The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line.

  1998cited by this paper
• Treatment of AIDS‐associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside.

  1998cited by this paper
• Activities of various compounds against murine and primate polyomaviruses

  1997cited by this paper
• The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Canadian PML Study Group.

  1995cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1989cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1988cited by this paper
• Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases.

  1987cited by this paper

• JC Polyomavirus Infection: A Narrative Review

  2025cites this paper
• Live long and persist: polyomavirus immune evasion in the brain and kidney.

  2025cites this paper
• Successful Treatment of Progressive Multifocal Leukoencephalopathy With Tenofovir Alafenamide Fumarate

  2025cites this paper
• Sintilimab for treating progressive multifocal leukoencephalopathy caused by human polyomavirus 2 virus infection following allogeneic hematopoietic cell transplantation: a case report

  2025cites this paper
• CNS infections in patients with hematological or oncological diseases (including cellular therapies) - 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

  2025cites this paper
• JC Virus-Related Retinopathy.

  2025cites this paper
• Biomarkers for progressive multifocal leukoencephalopathy: emerging data for use of JC virus DNA copy number in clinical trials.

  2024cites this paper
• Progressive multifokale Leukenzephalopathie: Diagnostik und Therapieoptionen

  2024cites this paper
• Polyomaviridae

  2024cites this paper
• Brincidofovir inhibits polyomavirus infection in vivo

  2024cites this paper
• GPCR Inhibitors Have Antiviral Properties against JC Polyomavirus Infection

  2024cites this paper
• Structural vaccinology, molecular simulation and immune simulation approaches to design multi-epitopes vaccine against John Cunningham virus.

  2024cites this paper
• Revisiting JC virus and progressive multifocal leukoencephalopathy

  2023cites this paper
• An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy

  2023cites this paper
• Progressive multifokale Leukenzephalopathie: Diagnostik und Therapieoptionen

  2023cites this paper
• Long-term prognosis and overall mortality in patients with progressive multifocal leukoencephalopathy

  2023cites this paper
• Innovative therapeutic concepts of progressive multifocal leukoencephalopathy

  2022cites this paper
• Progressive multifocal leukoencephalopathy associated with chemotherapy induced lymphocytopenia in solid tumors – case report of an underestimated complication

  2022cites this paper
• A Case of Progressive Multifocal Leukoencephalopathy in a Child with Hyper-Immunoglobulin M Syndrome: The Impact of Missed Care during the COVID-19 Pandemic

  2022cites this paper
• Neurologic Complications of Human Immunodeficiency Virus

  2021cites this paper
• Opportunistic infections of the central nervous system in human immunodeficiency virus-(HIV-) infected individuals

  2021cites this paper
• Progressive multifocal leukoencephalopathy in patients with immunovirological control and at least 6 months of combination antiretroviral therapy

  2021cites this paper
• Antivirals against human polyomaviruses: Leaving no stone unturned

  2021cites this paper
• An Unusual Case of Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient Masquerading as a Stroke

  2021cites this paper
• JC Polyomavirus and Transplantation: Implications for Virus Reactivation after Immunosuppression in Transplant Patients and the Occurrence of PML Disease

  2021cites this paper
• Progressive Multifocal Leukoencephalopathy in Children with Primary and Secondary Immune Deficiency.

  2021cites this paper
• Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome in seven patients with sarcoidosis: a critical discussion of treatment and prognosis

  2021cites this paper
• Off the Shelf Third Party Virus Specific T-Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplant Recipients.

  2021cites this paper
• Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease

  2020cites this paper
• Progressive multifocal leukoencephalopathy in multiple myeloma. A literature review and lessons to learn

  2020cites this paper
• Opportunistische Infektionen des Nervensystems bei AIDS

  2020cites this paper
• Fatal JC-virus Granular Cerebellar Neuronopathy associated with Autoimmune Lymphoproliferative Syndrome and Common Variable Immunode ciency

  2020cites this paper
• Central nervous system disease with JC virus infection in adults with congenital HIV.

  2020cites this paper
• Progressive multifokale Leukenzephalopathie – ein Update

  2020cites this paper
• [Neurological complications of JC virus infection: A review].

  2020cites this paper
• Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

  2020cites this paper
• Progressive multifocal leukoencephalopathy presenting with acute sensorineural hearing loss in an intestinal transplant recipient

  2020cites this paper
• Not a Disease of the Past: A Case Series of Progressive Multifocal Leukoencephalopathy in the Established Antiretroviral Era

  2019cites this paper
• Neurological Emergencies in the Immunocompromised Population

  2019cites this paper
• Progressive Multifocal Leukoencephalopathy in the Absence of Typical Radiological Changes: Can We Make a Diagnosis?

  2019cites this paper
• The spectrum of progressive multifocal leukoencephalopathy: a practical approach

  2019cites this paper
• Management of Infections in the Immunocompromised Host

  2018cites this paper
• Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy

  2018cites this paper
• The national incidence of PML in Sweden, 1988–2013

  2018cites this paper
• What the Intensivists Need to Know About Critically Ill Myeloma Patients

  2018cites this paper
• Infections in Hematopoietic Stem Cell Transplant Recipients

  2018cites this paper
• Progressive multifocal leukoencephalopathy.

  2018cites this paper
• How much progress has there been in the second-line treatment of multiple sclerosis: A 2017 update.

  2018cites this paper
• Do CCR5 antagonists improve the overall survival of patients with AIDS-related progressive multifocal leucoencephalopathy?

  2018cites this paper
• Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation: Case report and review of the literature

  2018cites this paper
• HTLV-1 Associated Neurological Disorders.

  2017cites this paper
• Leucoencéphalopathie multifocale progressive

  2017cites this paper
• Les infections opportunistes au cours de la sarcoïdose

  2017cites this paper
• Progressive multifocal leukoencephalopathy in the absence of immunosuppression

  2017cites this paper
• Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies

  2017cites this paper
• Inhibition of Retrograde Transport Limits Polyomavirus Infection In Vivo

  2017cites this paper
• 45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches

  2017cites this paper
• Progressive multi‐focal leucoencephalopathy – driven from rarity to clinical mainstream by iatrogenic immunodeficiency

  2017cites this paper
• [Opportunistic infections and sarcoidosis].

  2017cites this paper
• Prevention and therapy of JC polyomavirus-mediated progressive multifocal leukoencephalopathy - a realistic possibility?

  2017cites this paper
• A New Therapeutic Option for Progressive Multifocal Leukoencephalopathyafter Allogeneic Hematopoietic Cell Transplantation

  2017cites this paper
• Human Polyomavirus and Papillomavirus Infection and Disease Posttransplant

  2016cites this paper
• HIV-Associated Neurologic Disorders and Central Nervous System Opportunistic Infections in HIV

  2016cites this paper
• Clinical Trials in Neurovirology: Successes, Challenges, and Pitfalls

  2016cites this paper
• Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals

  2016cites this paper
• Effets indésirables des biothérapies dans la sclérose en plaques et les maladies apparentées

  2016cites this paper
• “All the soarings of my mind begin in my blood:” central nervous system complication of Waldenström macroglobulinemia

  2016cites this paper
• Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions

  2016cites this paper
• CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)—Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

  2016cites this paper
• Effetti collaterali delle bioterapie nella sclerosi multipla e nelle malattie correlate

  2016cites this paper
• Progressive multifocal leukoencephalopathy after liver transplantation can have favorable or unfavorable outcome

  2016cites this paper
• Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review

  2015cites this paper
• Progressive multifocal leukoencephalopathy therapy

  2015cites this paper
• Immune reconstitution inflammatory syndrome in a patient with progressive multifocal leukoencephalopathy

  2015cites this paper
• Long-Term Functional Prognosis of Patients with HIV-Associated Progressive Multifocal Leukoencephalopathy in the Era of Combination ART

  2015cites this paper
• The spectrum of opportunistic diseases complicating sarcoidosis.

  2015cites this paper
• Therapeutic Advances in Neurological Disorders

  2015cites this paper
• JC and BK polyomavirus-like particles as targets of innate and adaptive humoral immunity

  2015cites this paper
• DI-060 Due to this poster not being displayed at the 20th EAHP Congress, this abstract will not appear in the online version of the EJHP Abstract Supplement. The Scientific Committee of the EAHP

  2015cites this paper
• 131 – Management of Opportunistic Infections Associated with Human Immunodeficiency Virus Infection

  2015cites this paper
• DI-057 The contribution of the hospital pharmacy to the healthcare of patients on antiretroviral therapy: an identification of patient needs and an evaluation of services provided

  2015cites this paper
• 127 – Neurologic Diseases Caused by Human Immunodeficiency Virus Type 1 and Opportunistic Infections

  2015cites this paper
• DI-061 A case of progressive multifocal leukoencephalopathy; cidofovir treatment

  2015cites this paper
• Progressive multifocal leukoencephalopathy: current treatment options and future perspectives

  2015cites this paper
• Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.

  2015cites this paper
• The Biology and Clinical Consequence of Infection with the Human Polyomavirus JCV

  2014cites this paper
• Central nervous system infections in cancer patients and hematopoietic stem cell transplant recipients.

  2014cites this paper
• Immune surveillance and response to JC virus infection and PML

  2014cites this paper
• European perspective on human polyomavirus infection, replication and disease in solid organ transplantation.

  2014cites this paper
• Progressive multifocal leukoencephalopathy in patients with sarcoidosis

  2014cites this paper
• An animal model for progressive multifocal leukoencephalopathy.

  2014cites this paper
• Progressive Multifocal Leukoencephalopathy

  2014cites this paper
• Characterization of JC virus-specific CD4+ T cell epitopes in healthy individuals

  2014cites this paper
• Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation.

  2014cites this paper
• Capítulo 13 – Leucoencefalopatía multifocal progresiva

  2014cites this paper
• Antiviral Therapy for Progressive Multifocal Leukoencephalopathy

  2014influential citation
• Progressive Multifocal Leukoencephalopathy in Patients with a Hematological Malignancy: Review of Therapeutic Options

  2014cites this paper
• Update on opportunistic infections in the era of effective antiretroviral therapy.

  2014cites this paper
• CD8+-T-Zellen-Epitope aus Polyomavirus-Hüllprotein VP1 zur Impfung

  2014cites this paper
• Does Mefloquine (Lariam®) Therapy Improve the Prognosis of Human JC Polyomavirus-Induced Progressive Multifocal Leukoencephalopathy?

  2014cites this paper